Remove Business Development Remove Life Science Remove Pharma Companies
article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations? Mark holds a PhD in biomedicine, and an MSc in biostatistics.

article thumbnail

COVID-19 underscores need to boost pharma manufacturing in emerging markets

pharmaphorum

For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. India and China have seen the emergence of strong, local pharma companies. About the author. Dr Subir K.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why pharma isn’t yet achieving digital excellence, and how it can get there

pharmaphorum

This includes using its technology as a ‘ digital excellence cloud ’ to harness data, content management, insights and execution while also offering business consulting services to help pharma companies with strategy, processes, and change management. Veeva is the global leader in cloud software for the life sciences industry.

Sales 131
article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. While some patient groups are set up to work with industry, there are some who are more reticent about linking with pharma.

article thumbnail

LSX Inv€$tival Showcase round-up

pharmaphorum

On 14th November, investors and life science & healthcare executives descended on London’s famed Old Billingsgate building to attend LSX’s Inv€$tival Showcase, part of Europe’s biggest dedicated healthcare investment week. Investing in the future of the European life sciences. For Müllenbeck, this is an opportunity.

article thumbnail

What we’re expecting in 2021, and beyond…

pharmaphorum

No more ‘business as usual’ for pharma’s customer engagement. Life sciences companies need to rethink their customer engagement paradigms in light of changing customer preferences. We’re starting to see this happen through the emergence of smart homes and smart cars (i.e., About Healthware Group.

article thumbnail

Empowering rare disease patient advocacy organisations with data

pharmaphorum

During the pandemic, numerous digital health companies flourished due to the necessity for virtual solutions, including Komodo Health. He oversees operations, including business development, sales and marketing, and people. About the author.